A hemagglutinin quantification method for development of an influenza pandemic vaccine using size exclusion high performance liquid chromatography

Schild GC, Wood JM and Newman RW: A single-radial-immunodiffusion technique for the assay of influenza haemagglutinin antigen. Proposals for an assay method for the haemagglutinin content of influenza vaccines. Bull World Health Organ. 52:223–231. 1975.PubMed/NCBI

Wood JM, Schild GC, Newman RW and Seagroatt V: An improved single-radial-immunodiffusion technique for the assay of influenza haemagglutinin antigen: application for potency determinations of inactivated whole virus and subunit vaccines. J Biol Stand. 5:237–247. 1977. View Article : Google Scholar : PubMed/NCBI

Wood JM, Mumford J, Schild GC, Webster RG and Nicholson KG: Single-radial-immunodiffusion potency tests of inactivated influenza vaccines for use in man and animals. Dev Biol Stand. 64:169–177. 1986.PubMed/NCBI

Williams MS: Single-radial-immunodiffusion as an in vitro potency assay for human inactivated viral vaccines. Vet Microbiol. 37:253–262. 1993. View Article : Google Scholar : PubMed/NCBI

Hu J, Liu DC and Wang TR: Clinical application of the single radial immunodiffusion (SRID) technic to detect antitubercle bacillus antibody. Zhonghua Jie He He Hu Xi Za Zhi. 16:270–271. 318–279. 1993.(In Chinese).

Gerdil C: The annual production cycle for influenza vaccine. Vaccine. 21:1776–1779. 2003. View Article : Google Scholar : PubMed/NCBI

Kapteyn JC, Saidi MD, Dijkstra R, et al: Haemagglutinin quantification and identification of influenza A&B strains propagated in PER. C6 cells: a novel RP-HPLC method. Vaccine. 24:3137–3144. 2006. View Article : Google Scholar : PubMed/NCBI

Kapteyn JC, Porre AM, de Rond EJ, et al: HPLC-based quantification of haemagglutinin in the production of egg- and MDCK cell-derived influenza virus seasonal and pandemic vaccines. Vaccine. 27:1468–1477. 2009. View Article : Google Scholar

Garcia-Canas V, Lorbetskie B, Bertrand D, Cyr TD and Girard M: Selective and quantitative detection of influenza virus proteins in commercial vaccines using two-dimensional high-performance liquid chromatography and fluorescence detection. Anal Chem. 79:3164–3172. 2007. View Article : Google Scholar : PubMed/NCBI

Williams TL, Luna L, Guo Z, et al: Quantification of influenza virus hemagglutinins in complex mixtures using isotope dilution tandem mass spectrometry. Vaccine. 26:2510–2520. 2008. View Article : Google Scholar : PubMed/NCBI

Peyre M, Fusheng G, Desvaux S and Roger F: Avian influenza vaccines: a practical review in relation to their application in the field with a focus on the Asian experience. Epidemiol Infect. 137:1–21. 2009. View Article : Google Scholar

Li C, Shao M, Cui X, et al: Application of deglycosylation and electrophoresis to the quantification of influenza viral hemagglutinins facilitating the production of 2009 pandemic influenza (H1N1) vaccines at multiple manufacturing sites in China. Biologicals. 38:284–289. 2010. View Article : Google Scholar : PubMed/NCBI

Wood JM and Levandowski RA: The influenza vaccine licensing process. Vaccine. 21:1786–1788. 2003. View Article : Google Scholar : PubMed/NCBI

Ferguson NM, Cummings DA, Fraser C, Cajka JC, Cooley PC and Burke DS: Strategies for mitigating an influenza pandemic. Nature. 442:448–452. 2006. View Article : Google Scholar : PubMed/NCBI